What's Rolled Up: Cannabis Reclassification

Dear Members

We have some crucial news regarding the regulatory landscape of cannabis. 

The United States is actively drafting a reclassification for cannabis, marking a pivotal step in its regulation.

Who is Involved? The reclassification process is being overseen by several federal agencies, including the Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA).

These agencies are working together to reassess cannabis's classification under the Controlled Substances Act (CSA).What is Happening? 

The reclassification aims to shift cannabis from its current Schedule I status, which denotes it as having no accepted medical use and a high potential for abuse, to a lower schedule. This would acknowledge its medical benefits and regulate it in a manner similar to other controlled substances that have recognized medical uses.  

When is This Taking Place? 

The drafting process is ongoing, with a series of public comment periods and reviews scheduled over the coming months. Stakeholders, including industry members, healthcare professionals, and the public, are encouraged to provide input during these periods to shape the final regulations. 

How Will It Happen? 

The process involves several steps: Public Comment: Initial drafts and proposals are published for public feedback. 

This is where your input is invaluable.  

Review and Revision: Feedback is reviewed, and necessary revisions are made to the proposals.  Final Rulemaking: Once revisions are complete, the final reclassification rule is published and implemented.  

To participate and provide your feedback, please visit the public comment section on Regulations.gov .

Your involvement is crucial in ensuring that the reclassification reflects a balanced and informed perspective, benefiting both the industry and consumers. 

Thank you for your continued support and active participation!

Best,

Dakarai

Watershed Rolling Paper